anmelden
Novo Nordisk Aktie
42,10
EUR
+0,35
EUR
+0,83
%
42,20
EUR
+0,38
EUR
+0,90
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
|
Werbung
|
|||
| 14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
| 05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
| 05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
| 07.07.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 24.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 10.06.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.06.21 | Novo Nordisk Outperform | Bernstein Research | |
| 10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.06.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 01.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 21.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk overweight | Barclays Capital | |
| 05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 05.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.03.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 16.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
Werbung
Werbung